Skip to main content

Table 7 Association between side effects and COMT rs4680 polymorphism in the studies included in the systematic review

From: Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review

Study name [ref]

Variable

Genotype frequency (N, %)

Results (type of measure)

p-value

EPOS study [20] (Barratt, 2015)

Tiredness, Depression, Cognitive Dysfunction, Constipation

G/G (109, 23.59)

A/G (243, 52.60)

A/A (110, 23.80)

Not reported

 

[21] (Laugsand, 2011)

Nausea and Vomiting EORTC Score

G/G (341, 21.93)

A/G (787, 50.61)

A/A (427, 27.46)

25.8 ± 30.5

21.5 ± 26.6

26.2 ± 29.2

(mean ± SD)

0.002

[23] RakvĂĄg, 2005

Fatigue EORTC Score

G/G (44, 21.25)

A/G (96, 46.38)

A/A (67, 32.37)

73 ± 23

62 ± 24

66 ± 22

(mean ± SD)

> 0.05

 

Nausea and vomiting EORTC Score

 

30 ± 27

24 ± 26

29 ± 27

(mean ± SD)

> 0.05

 

Dyspnea EORTC Score

 

39 ± 35

38 ± 34

32 ± 33

(mean ± SD)

> 0.05

 

Sleep EORTC Score

 

39 ± 35

38 ± 34

32 ± 33

(mean ± SD)

> 0.05

 

Appetite EORTC Score

 

64 ± 36

49 ± 38

53 ± 38

(mean ± SD)

> 0.05

 

Constipation EORTC Score

 

56 ± 41

57 ± 37

54 ± 37

(mean ± SD)

> 0.05

[28] Ross, 2008

Central side effect

G/G (46, 20.81)

A/G (119, 53.85)

A/A (56, 25.34)

Not reported

0.956

  1. EORTC European Organization for Research and Treatment of Cancer Core